Hayley Evans/LinkedIn
Jul 22, 2026, 08:58
Hayley Evans: Exploring TXA in Surgery and Its Role in Reducing Blood Loss
Hayley Evans, Deputy Director at the NIHR Blood and Transplant Research Unit in Data Driven Transfusion Practice, shared a post on LinkedIn:
“Many of you will be aware of the growing evidence around tranexamic acid (TXA) in surgery and its role in reducing blood loss.
Our new Medscape piece ‘Implementing Updated NICE Guidance on Tranexamic Acid in Surgery:
Moving from Evidence to Routine Practice’ looks at practical steps to help increase appropriate TXA use and support more consistent routine practice.”
Stay updated with Hemostasis Today.
-
Sep 20, 2026, 13:29Factor XI Deficiency and the Challenge of Unpredictable Bleeding – EHC
-
Sep 20, 2026, 13:18Cindy Howry: FDA Approves First Treatment for Ataxia-Telangiectasia
-
Sep 20, 2026, 13:08Mohammad Salar Amoli: When Routine Coagulation Tests Miss von Willebrand Disease
-
Sep 20, 2026, 12:55Stelios Andreadis։ Human Salivary Gland Organoids Offer New Potential for Regenerative Medicine
-
Sep 20, 2026, 12:43Obi Light Ogbonnia: The Power of Lived Experience in Sickle Cell Care
-
Sep 20, 2026, 12:34Sabrine Mekni: Advancing HSCT for Children With Fanconi Anemia
-
Sep 20, 2026, 12:11Giacomo Buso: Silent Atherosclerosis Begins Earlier Than Expected
-
Sep 20, 2026, 12:0310 Posts Not to Miss This Week
-
Sep 20, 2026, 11:27Edward Lee Carter: Prasugrel Dosing Matters in P2Y12 Inhibitor Comparisons After PCI